17.

Cohen J, Collins R, Darkes J, Gwartney D. A league of their own: demo-

graphics, motivations and patterns of use of 1,955 male adult nonmedical

anabolic steroid users in the United States. J Int Soc Sports Nutr 2007;4:12

18.

Bauermeister JA, Zimmerman MA, Johns MM, Glowacki P, Stoddard S,

Volz E. Innovative recruitment using online networks: lessons learned

from an online study of alcohol and other drug use utilizing a web-

based, respondent-driven sampling (webRDS) strategy. J Stud Alcohol

Drugs 2012;73:834

–

19.

Evans NA. Gym and tonic: a pro

le of 100 male steroid users. Br J Sports

Med 1997;31:54

–

20.

Hildebrandt T, Langenbucher J, Carr S, Sanjuan P, Park S. Predicting inten-

tions for long-term anabolic-androgenic steroid use among men: a covari-

ance structure model. Psychol Addict Behav 2006;20:234

–

21.

Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. The Anabolic 500 survey: char-

acteristics of male users versus nonusers of anabolic-androgenic steroids

for strength training. Pharmacotherapy 2011;31:757

–

22.

McCabe SE. Comparison of web and mail surveys in collecting illicit drug

use data: a randomized experiment. J Drug Educ 2004;34:61

–

23.

McCabe SE, Boyd CJ, Young A, Crawford S, Pope D. Mode effects for col-

lecting alcohol and tobacco data among 3rd and 4th grade students: a

randomized pilot study of Web-form versus paper-form surveys. Addict

Behav 2005;30:663

–

24.

Miller PG, Sønderlund AL. Using the Internet to research hidden popula-

tions of illicit drug users: a review. Addiction 2010;105:1557

–

25.

Perry HM, Wright D, Littlepage BN. Dying to be big: a review of anabolic

steroid use. Br J Sports Med 1992;26:259

–

26.

Young A, McCabe SE, Cranford JA, Ross-Durow P, Boyd CJ. Nonmedical

use of prescription opioids among adolescents: subtypes based on motiva-

tion for use. J Addict Dis 2012;31:332

–

27.

Franke WW, Berendonk B. Hormonal doping and androgenization of ath-

letes: a secret program of the German Democratic Republic government.

Clin Chem 1997;43:1262

–

28.

€

oqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic

steroids, in sports and society. Lancet 2008;371:1872

–

29.

de Souza GL, Hallak J. Anabolic steroids and male infertility: a comprehen-

sive review. BJU Int 2011;108:1860

–

30.

Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the

Future national survey results on drug use. Vol. I: Secondary school stu-

dents. Ann Arbor: Institute of Social Research, University of Michigan;

2013

31.

Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Anabolic-andro-

genic steroid dependence: an emerging disorder. Addiction 2009;104:

1966

–

32.

Perry PJ, Lund BC, Deninger MJ, Kutscher EC, Schneider J. Anabolic steroid

use in weightlifters and bodybuilders: an internet survey of drug utilization.

Clin J Sport Med 2005;15:326

–

33.

Pirola I, Cappelli C, Delbarba A, Scalvini T, Agosti B, Assanelli D, et al.

Anabolic steroids purchased on the Internet as a cause of prolonged hypo-

gonadotropic hypogonadism. Fertil Steril 2010;94:2331.e1

–

34.

Cooper ER, McGrath KCY, Heather AK. In vitro androgen bioassays as a

detection method for designer androgens. Sensors 2013;13:2148

–

35.

Cordaro FG, Lombardo S, Cosentino M. Selling androgenic anabolic

steroids by the pound: identi

cation and analysis of popular websites on

the Internet. Scand J Med Sci Sports 2011;21:e247

–

36.

Baume N, Mahler N, Kamber M, Mangin P, Saugy M. Research of stimu-

lants and anabolic steroids in dietary supplements. Scand J Med Sci Sports

2006;16:41

–

37.

Cavalcanti Gd A, Leal FD, Garrido BC, Padilha MC, de Aquino Neto FR.

Detection of designer steroid methylstenbolone in

‘‘

nutritional supple-

ment

’’

using gas chromatography and tandem mass spectrometry: elucida-

tion of its urinary metabolites. Steroids 2013;78:228

–

38.

Geyer H, Parr MK, Koehler K, Mareck U, Sch

€

anzer W, Thevis M. Nutritional

supplements cross-contaminated and faked with doping substances.

J Mass Spectrom 2008;43:892

–

902

39.

Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Sch

€

anzer W. Analysis

of nonhormonal nutritional supplements for anabolic-androgenic ste-

roids

—

results of an international study. Int J Sports Med 2004;25:124

–

40.

Parr MK, Geyer H, Hoffmann B, K

€

ohler K, Mareck U, Sch

€

anzer W. High

amounts of 17-methylated anabolic-androgenic steroids in effervescent

tablets on the dietary supplement market. Biomed Chromatogr 2007;21:

164

–

41.

Vilella AL, Limsuwat C, Williams DR, Seifert CF. Cholestatic jaundice as a

result of combination designer supplement ingestion. Ann Pharmacother

2013;47:e33

42.

Cohen PA. Assessing supplement safety

—

the FDA's controversial pro-

posal. N Engl J Med 2012;366:389

–

43.

Pope HG, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid

users' attitudes toward physicians. Addiction 2004;99:1189

–

44.

Kanayama G, Pope HG Jr. Illicit use of androgens and other hormones:

recent advances. Curr Opin Endocrinol Diabetes Obes 2012;19:211

–

45.

Tan RS, Scally MC. Anabolic steroid-induced hypogonadism

—

toward a

uni

ed hypothesis of anabolic steroid action. Med Hypotheses 2009;72:

723

–

46.

Boregowda K, Joels L, Stephens JW, Price DE. Persistent primary hypogo-

nadism associated with anabolic steroid abuse. Fertil Steril 2011;96:e7

–

47.

Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Issues for

DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid

dependence. Am J Psychiatry 2009;166:642

–

48.

Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports

Med 2004;32:534

–

49.

Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of

anabolic steroids in athletes. A constant threat. Toxicol Lett 2005;158:

167

–

50.

Moretti E, Collodel G, La Marca A, Piomboni P, Scapigliati G, Baccetti B.

Structural sperm and aneuploidies studies in a case of spermatogenesis re-

covery after the use of androgenic anabolic steroids. J Assist Reprod Genet

2007;24:195

–

51.

Graham MR, Davies B, Grace FM, Kicman A, Baker JS. Anabolic steroid use:

patterns of use and detection of doping. Sports Med 2008;38:505

–

52.

Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI. The treatment of

hypogonadism in men of reproductive age. Fertil Steril 2013;99:718

–

53.

Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Hormonal

Male Contraception Summit Group. Rate, extent, and modi

ers of sper-

matogenic recovery after hormonal male contraception: an integrated

analysis. Lancet 2006;367:1412

–

54.

Arce JC, de Souza MJ. Exercise and male factor infertility. Sports Med 1993;

15:146

–

55.

Boettcher M, Kosmehl T, Braunbeck T. Low-dose effects and biphasic ef-

fect pro

les: is trenbolone a genotoxicant? Mutat Res 2011;723:152

–

56.

Chainy GBN, Samantaray S, Samanta L. Testosterone-induced changes in

testicular antioxidant system. Andrologia 1997;29:343

–

57.

Karila T, Hovatta O, Sepp

€

a T. Concomitant abuse of anabolic androgenic

steroids and human chorionic gonadotrophin impairs spermatogenesis in

power athletes. Int J Sports Med 2004;25:257

–

58.

Shokri S, Aitken RJ, Abdolvahhabi M, Abolhasani F, Ghasemi FM, Kashani I,

et al. Exercise and supraphysiological dose of nandrolone decanoate in-

crease apoptosis in spermatogenic cells. Basic Clin Pharmacol Toxicol

2010;106:324

–

59.

Harkness RA, Kilshaw BH, Hobson BM. Effects of large doses of anabolic

steroids. Br J Sports Med 1975;9:70

–

60.

Braunstein GD. Aromatase and gynecomastia. Endocr Relat Cancer 1999;

6:315

–

61.

LeRoith D, Sobel R, Glick SM. The effect of clomiphene citrate on pubertal

gynaecomastia. Acta Endocrinol (Copenh) 1980;95:177

–

62.

Plourde PV, Kulin HE, Santner SJ. Clomiphene in the treatment of adoles-

cent gynecomastia. Clinical and endocrine studies. Am J Dis Child 1983;

137:1080

–

63.

Serels S, Melman A. Tamoxifen as treatment for gynecomastia and masto-

dynia resulting from hormonal deprivation. J Urol 1998;159:1309

64.

Staiman VR, Lowe FC. Tamoxifen for

ﬂ

utamide/

nasteride

–

induced

gynecomastia. Urology 1997;50:929

–

65.

Stepanas AV, Burnet RB, Harding PE, Wise PH. Clomiphene in the treat-

ment of pubertal-adolescent gynecomastia: a preliminary report. J Pediatr

1977;90:651

–

1278

VOL. 101 NO. 5 / MAY 2014

ORIGINAL ARTICLE: ANDROLOGY